Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Stock data | 2025 | Change |
---|---|---|
Price | $0.12 | N/A |
Market Cap | $7.09M | N/A |
Shares Outstanding | 59.09M | N/A |
Employees | 2.00 | N/A |